Clinical Affairs

Kymanox understands that clinical decision making is a contextual, continuous, and evolving process in which data are gathered, interpreted, and evaluated to develop an evidence-based choice of action. We approach clinical evaluation of complex combination products with a multi-disciplinary, risk-based approach while engaging our board-certified Medical Doctors, PhD-, and MPH-level Subject Matter Experts (SMEs) in regulatory affairs, safety, statistics, and engineering (e.g., biomedical, chemical).